Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mary Beth Lewis Insider Profile
4 Followers
Mary Beth Lewis, Director at Eterna Therapeutics, holds 40.00K shares in Eterna Therapeutics (Ticker: ERNA). Most recently, Mary Beth Lewis Bought $30,000 shares of Eterna Therapeutics on Aug 25, 2010 for an estimated value of 5.40K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+23.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Mary Beth Lewis's holdings
Insider Roles
Director
Roles that Mary Beth Lewis holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 27, 2009 - May 27, 2010
Return:+48.60%
The most profitable trade made by Mary Beth Lewis
Mary Beth Lewis's Trading History
List of latest transactions for each holding click on a transaction to see Mary Beth Lewis's performance on stock
You May Also Like
Mary Beth Lewis insider profile FAQ
What is the percentage of profitable transactions made by Mary Beth Lewis?
The percentage of profitable transactions made by Mary Beth Lewis is 50%.
What is the average return per transaction made by Mary Beth Lewis?
The average return per transaction made by Mary Beth Lewis is 23.10%.
What stocks does Mary Beth Lewis hold?
Mary Beth Lewis holds: ERNA stocks.
What was Mary Beth Lewis’s latest transaction?
Mary Beth Lewis latest transaction was an Informative Buy of $5.40K.
What was Mary Beth Lewis's most profitable transaction?
Mary Beth Lewis’s most profitable transaction was an Informative Buy of ERNA stock on May 27, 2009. The return on the trade was 48.60%.
What is Mary Beth Lewis's role in Eterna Therapeutics?
Mary Beth Lewis's role in Eterna Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.